Quality improvement interventions to prevent healthcare-associated infections in neonates and children

Current Opinion in Pediatrics

Volumn 24, Issue 1, 2012, Pages 103-112

  Huskins, W Charles ^a  

^a MAYO CLINIC   (United States)

Author keywords

central line associated bloodstream infection; cross infection; healthcare; healthcare associated infection; infection control; quality assurance; quality improvement

Indexed keywords

BLOODSTREAM INFECTION; CATHETER INFECTION; CROSS INFECTION; HEALTH CARE; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; NEWBORN INFECTION; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TOTAL QUALITY MANAGEMENT;

CATHETER-RELATED INFECTIONS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, PEDIATRIC; MALE; QUALITY IMPROVEMENT;

EID: 84856100736     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32834ebdc3     Document Type: Review

References (64)

1. Centers for Disease Control and Prevention. Vital signs: central line-associated blood stream infections - United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011; 60:243-248. A report from the CDC's NHSN describes a 58% decrease in the incidence of CLABSI in US ICU in 2009 compared with 2001. The reduction in CLABSI was greatest for Staphylococcus aureus CLABSIs (73% reduction) and more modest for CLABSIs caused by Gram-negative pathogens (37% reduction), Candida spp. (46% reduction), and Enterococcus spp. (55% reduction).
2. Pronovost PJ, Marsteller JA, Goeschel CA. Preventing bloodstream infections: a measurable national success story in quality improvement. Health Aff (Millwood) 2011; 30:628-634. This publication describes how the effort to reduce CLABSI that began in Michigan and has subsequently been extended nationally serves as a 'case model' of a successful patient safety initiative. The article describes how the alignment of stakeholders with a unified sense of measurable goals, social and policy pressures, and management, financial, and regulatory levers can be combined to create incentive, drive change, and hold healthcare organizations accountable for better patient safety performance.
3. Wachter RM. Patient safety at ten: unmistakable progress, troubling gaps. Health Aff (Millwood) 2010; 29:165-173. This editorial reviews the efforts to improve patient safety during the decade of the 2000s, identifying important improvements as well as areas where progress has been inadequate and barriers to change still exist.
4. Landrigan CP, Parry GJ, Bones CB, et al. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med 2010; 363:2124-2134. This retrospective study identified rates of harm to patients in a stratified random sample of 10 hospitals in North Carolina from 2002 through 2007. The incidence of harm was 25 per 100 admissions, with a small and not significant rate of reduction in preventable harms during the study period.
5. Cardo D, Dennehy PH, Halverson P, et al. Moving toward elimination of healthcare-associated infections: a call to action. Infect Control Hosp Epidemiol 2010; 31:1101-1105. Led by the CDC, a group of governmental agencies and professional societies call for effort to eliminate healthcare-associated infections by promoting adherence to evidence-based prevention practices; aligning financial incentives and reinvestment in successful strategies; addressing knowledge gaps to respond to emerging threats through basic, translational, and epidemiological research; and collecting data to target prevention efforts and to measure progress.
6. Umscheid CA, Mitchell MD, Doshi JA, et al. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011; 32:101-114. This systematic review estimates that as many as 65-70% of cases of CLABSI and catheter-associated urinary tract infection and 55% of cases of ventilatorassociated pneumonia and surgical site infection may be 'reasonably preventable' with existing evidence-based practice. From these data, the investigators calculated the annual number of preventable infections and deaths and costs for each type of healthcare-associated infection.
7. Graves N, Harbarth S, Beyersmann J, et al. Estimating the cost of healthcareassociated infections: mind your p's and q's. Clin Infect Dis 2010; 50:1017-1021. This perspective critically reviews the literature on estimates of the economic costs of healthcare-associated infections and concludes current estimates are likely overestimates due to the inability to adequately control for confounding variables that are associated with both infections and cost and the failure to consider timedependent bias in calculating costs.
8. Graves N, Barnett AG, Halton K, et al. The importance of good data, analysis, and interpretation for showing the economics of reducing healthcare-associated infection. Infect Control Hosp Epidemiol 2011; 32:927-928. This letter to the editor critiques the methods and findings of Ref. [6 ].
9. Association for Professionals in Infection Control and Epidemiology, Inc. HAI reporting laws and regulations. Available from http://www.apic.org/ downloads/ legislation/HAI-map.gif. [Accessed 31 August 2011]
10. Centers for Disease Control and Prevention. First state-specific healthcareassociated infections summary data report: CDC's National Healthcare Safety Network (NHSN) January-June, 2009. Available from http:// www.cdc.gov/hai/statesummary.html. [Accessed 31 August 2011]
11. Consumers Union. Teaching hospitals not always best for patient safety. Available from http://news.consumerreports.org/health/2011/06/teachinghospitals- not-always-best-for-patient-safety.html. [Accessed 31 August 2011]
12. McCannon J, Berwick DM. A new frontier in patient safety. JAMA 2011; 305:2221-2222. This publication announces a new national effort to improve patient safety, the 'Partnership for Patients', led by the United States Department of Health and Human Services. The aims of the project are to accelerate the reduction of harmto patients in hospitals and to decrease preventable hospital readmissions within 30 days of discharge. The program expects to reduce injuries to patients and readmission rates substantially, with resulting decreases in inpatient deaths and healthcare costs.
13. Foster CB, Sabella C. Healthcare-associated infections in children. JAMA 2011; 305:1480-1481. This commentary outlines the priorities for efforts to reduce healthcare-associated infections in children.
14. Steering Committee on Quality Improvement and Management and Committee on Hospital Care, American Academy of Pediatrics. Policy statement - principles of pediatric patient safety: reducing harm due to medical care. Pediatrics 2011; 127:1199-1210. This policy statement from the American Academy of Pediatrics makes recommendations related to three efforts necessary to reduce harm due to medical care in children: raising awareness and improving knowledge of pediatric patient safety issues and best practices throughout the pediatric community; acting and advocating to minimize preventable pediatric medical harm by using information on pediatricspecific patient safety risk; and improving healthcare outcomes for children by adhering to proven best practices for improving pediatric patient safety.
15. Nowak JE, Brilli RJ, Lake MR, et al. Reducing catheter-associated bloodstream infections in the pediatric intensive care unit: business case for quality improvement. Pediatr Crit Care Med 2010; 11:579-587. This matched cohort study calculated the excess length of stay and healthcare costs attributable to central line-associated bloodstream infection in a pediatric ICU. Using this information, the authors describe a business case for quality improvement efforts to reduce these infections.
16. Levy FH, Brilli RJ, First LR, et al. A new framework for quality partnerships in children's hospitals. Pediatrics 2011; 127:1147-1156. In this article, hospital executives and pediatric department chairs from 14 children's hospitals discuss their efforts to integrate quality programs, with focus on: aligning quality priorities and resources across the organizations; educating and training for physicians in the science of improvement; and professional development and career progression for physicians in recognition of quality improvement activities.
17. Schulman J, Wirtschafter DD, Kurtin P. Neonatal intensive care unit collaboration to decrease hospital-acquired bloodstream infections: from comparative performance reports to improvement networks. Pediatr Clin North Am 2009; 56:865-892.
18. Horbar JD, Soll RF, Edwards WH. The Vermont Oxford Network: a community of practice. Clin Perinatol 2010; 37:29-47. This article reviews the work of the Vermont Oxford Network in improving neonatal care.
19. Jeffries HE, Mason W, Brewer M, et al. Prevention of central venous catheterassociated bloodstream infections in pediatric intensive care units: a performance improvement collaborative. Infect Control Hosp Epidemiol 2009; 30:645-651.
20. Miller MR, Griswold M, Harris JM, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics 2010; 125:206-213. This time series study, coordinated through the National Association of Children's Hospitals and Related Institutions, describes a quality improvement intervention to reduce CLABSI in 29 pediatric intensive care units. The average incidence of CLABSI decreased from 5.4 to 3.1 per 1000 central line days.
21. Lachman P, Yuen S. Using care bundles to prevent infection in neonatal and paediatric ICUs. Curr Opin Infect Dis 2009; 22:224-228.
22. Sandora TJ. Prevention of healthcare-associated infections in children: new strategies and success stories. Curr Opin Infect Dis 2010; 23:300-305.
23. Graham PL. Simple strategies to reduce healthcare associated infections in the neonatal intensive care unit: line, tube, and hand hygiene. Clin Perinatol 2010; 37:645-653.
24. Powers RJ, Wirtschafter DW. Decreasing central line associated bloodstream infection in neonatal intensive care. Clin Perinatol 2010; 37:247-272.
25. Li S, Bizzarro MJ. Prevention of central line associated bloodstream infections in critical care units. Curr Opin Pediatr 2011; 23:85-90.
26. Leape LL, BerwickDM, Bates DW.What practices willmost improve safety? Evidence-based medicine meets patient safety. JAMA 2002; 288:501-507. (Pubitemid 34787485)
27. Shojania KG, Duncan BW, McDonald KM, Wachter RM. Safe but sound: patient safety meets evidence-based medicine. JAMA 2002; 288:508-513. (Pubitemid 34787486)
28. Auerbach AD, Landefeld CS, Shojania KG. The tension between needing to improve care and knowing how to do it. N Engl J Med 2007; 357:608-613. (Pubitemid 47236290)
29. Berwick D.M. The science of improvement JAMA 2008 299 1182-1184
30. Berwick DM. The science of improvement. JAMA 2008; 299:1182-1184. 30. Ogrinc G, Mooney SE, Estrada C, et al. The SQUIRE (Standards for Quality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration. Qual Saf Healthcare 2008; 17 (Suppl. 1):i13-i32.
31. Fan E, Laupacis A, Pronovost PJ, et al. How to use an article about quality improvement. JAMA 2010; 304:2279-2287. This 'Users' Guide to the Medical Literature' focuses on how to review and use reports of studies examining the effects of quality improvement interventions.
32. Shekelle PG, Pronovost PJ, Wachter RM, et al. Advancing the science of patient safety. Ann Intern Med 2011; 154:693-696. Sponsored by the Agency for Healthcare Research and Quality, an international group of experts in patient safety and evaluation methods recommend that reports of interventions to improve patient safety should include greater use of theory and logic models, more detailed descriptions of interventions and their implementation, enhanced explanation of desired and unintended outcomes, and better description and measurement of context and of how context influences interventions.
33. Harris AD, Bradham DD, Baumgarten M, et al. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis 2004; 38:1586-1591. (Pubitemid 38738556)
34. Shardell M, Harris AD, El-Kamary SS, et al. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007; 45:901-907. (Pubitemid 47580386)
35. Stone SP, Cooper BS, Kibbler CC, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 2007; 7:282-288. (Pubitemid 46420801)
36. Aly H, Herson V, Duncan A, et al. Is bloodstream infection preventable among premature infants? A tale of two cities. Pediatrics 2005; 115:1513-1518. (Pubitemid 43843158)
37. McKee C, Berkowitz I, Cosgrove SE, et al. Reduction of catheter-associated bloodstream infections in pediatric patients: experimentation and reality. Pediatr Crit Care Med 2008; 9:40-46.
38. Costello JM, Morrow DF, Graham DA, et al. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008; 121:915-923.
39. Bizzarro MJ, Sabo B, Noonan M, et al. A quality improvement initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010; 31:241-248. This single-center, before/after study describes a quality improvement intervention to reduce CLABSI in a neonatal ICU. The incidence of CLABSI decreased from 8.4 to 1.3 cases per 1000 central line days and the incidence of late-onset sepsis decreased from 5.8 to 1.4 cases per 1000 patient-days.
40. Kilbride HW, Wirtschafter DD, Powers RJ, Sheehan MB. Implementation of evidence-based potentially better practices to decrease nosocomial infections. Pediatrics 2003; 111:e519-e533.
41. Kilbride HW, Powers R, Wirtschafter DD, et al. Evaluation and development of potentially better practices to prevent neonatal nosocomial bacteremia. Pediatrics 2003; 111:e504-e518.
42. Wirtschafter DD, Powers RJ, Pettit JS, et al. Nosocomial infection reduction in VLBW infants with a statewide quality-improvement model. Pediatrics 2011; 127:419-426. This multicenter, statewide, before/after study, coordinated through the California Perinatal Quality Care Collaborative, describes a quality improvement intervention to reduce nosocomial infection in 54 neonatal ICUs. Across all ICUs, the rate of nosocomial infection decreased from 16.9% in 2002 to 14.5% in 2006. Infants admitted to ICUs participating in at least one quality improvement event had a lower risk of nosocomial infection compared with those admitted to nonparticipating units.
43. Schulman J, Stricof R, Stevens TP, et al. Statewide NICU central-lineassociated bloodstream infection rates decline after bundles and checklists. Pediatrics 2011; 127:436-444. This multicenter, statewide, before/after study, coordinated by a network of regional referral neonatal ICUs and the State of New York Heath Department, describes a quality improvement intervention to reduce CLABSI in 18 neonatal ICUs. Across all ICUs, the incidence of CLABSI decreased from 6.4 to 2.1 (from 3.5 to 2.1 using the current 2008 NHSN CLABSI definition) per 1000 central line days. Greater use of a maintenance checklist was associated with a lower incidence of CLABSI. The study also explored the degree of heterogeneity in results among units.
44. Miller MR, Niedner MF, Huskins WC, et al. Reduction of PICU central lineassociated bloodstream infections: 3-year results. Pediatrics 2011; 128: e1077-e1083. This time series study, coordinated through the National Association of Children's Hospitals and Related Institutions, describes a follow-up assessment of the quality improvement intervention to reduce CLABSI in 29 pediatric ICUs described initially in Ref. [20 ]. Over 3 years of the intervention, the incidence of CLABSI decreased from 5.4 to 2.3 per 1000 central line days. The study found that 15% of the decrease was due to the 2008 change in NHSN definition of CLABSIs.
45. Kaplan HC, Lannon C, Walsh MC, Donovan EF. Ohio statewide qualityimprovement collaborative to reduce late-onset sepsis in preterm infants. Pediatrics 2011; 127:427-435. This multi-center, statewide, time-series study, coordinated through the Ohio Perinatal Quality Collaborative, describes the effect of a QI intervention to reduce late onset sepsis in preterm infants in 24 neonatal ICUs. Aggregate adherence to a central line insertion bundle increased to >90% after 7 months and remained high throughout the remainder of the study. Aggregate adherence to a central line maintenance bundle increased slowly and reached 80% only after 15 months (the last month of the study). Across all ICUs, late onset sepsis decreased in preterm infants from 18.2% in 2006-2008 to 14.3% in 2008-2009.
46. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32:2014-2020. (Pubitemid 39372534)
47. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-2732. (Pubitemid 46021509)
48. Pronovost PJ, Goeschel CA, Colantuoni E, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 2010; 340:c309. This time series study describes a follow-up assessment of the Michigan Keystone Project quality improvement intervention to reduce CLABSI in 90 adult intensive care units described initially in Ref. [46]. Over 3 years of the intervention, the median incidence of CLABSI decreased from 2.7 to 0 per 1000 central line days.
49. DePalo VA, McNicoll L, Cornell M, et al. The Rhode Island ICU collaborative: a model for reducing central line-associated bloodstream infection and ventilatorassociated pneumonia statewide. Qual Saf Healthcare 2010; 19:555-561.
50. Maragakis LL, Bradley KL, Song X, et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 2006; 27:67-70. (Pubitemid 46939753)
51. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485
52. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37:783-805.
53. Sengupta A, Lehmann C, Diener-West M, et al. Catheter duration and risk of CLA-BSI in neonates with PICCs. Pediatrics 2010; 125:648-653.
54. Niedner MF, Huskins WC, Colantuoni E, et al. Epidemiology of central line associated bloodstream infections in the pediatric intensive care unit. Infect Control Hosp Epidemiol 2011; 32:1200-1208.
55. Langley GL, Nolan KM, Nolan TW, et al. The improvement guide: a practical approach to enhancing organizational performance. 2nd ed. San Francisco: Jossey-Bass Publishers; 2009.
56. Institute for Healthcare Improvement. Science of improvement: how to improve. Available from http://www.ihi.org/knowledge/Pages/HowtoIm prove/ScienceofImprovementHowtoImprove.aspx. [Accessed 26 August 2011]
57. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002; 51:1-29.
58. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-332. (Pubitemid 351763841)
59. Vermont Oxford Network. Vermont Oxford Network Database Manual of Operations for Infants Born in 2009. 2009. Release 13.2. Available from www.vtoxford.org/tools/2009manualofoperationswithindex13-2.pdf. [Accessed 26 August 2011]
60. Schulman J, Stricof RL, Stevens TP, et al. Development of a statewide collaborative to decrease NICU central line-associated bloodstream infections. J Perinatol 2009; 29:591-599.
61. Lin MY, Hota B, Khan YM, et al. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010; 304:2035-2041. This retrospective cohort study examined institutional variation in performance of traditional CLABSI surveillance in 20 ICUs at four medical centers. The incidence of CLABSI determined by infection preventionists using the NHSN CLABSI definition was lower than that determined by a computer algorithm reference standard applied retrospectively using criteria adapted from CDC surveillance definitions. The overall correlation between rates determined by the infection preventionists and computer algorithm was weak. The study concluded that there is significant variation in the application of the CLABSI definition across medical centers, which may complicate interinstitutional comparisons of publicly reported CLABSI rates.
62. Niedner MF. The harder you look, the more you find: catheter-associated bloodstreaminfection surveillance variability.AmJ Infect Control 2010; 38:585-595. This survey of healthcare professionals in 16 pediatric ICUs found substantial variation in methods, timing, and resources used to screen and adjudicate CLABSI cases. A surveillance aggressiveness score was devised to quantify practices likely to increase identification of bloodstream infections, and found a significant positive correlation between the score and the reported incidence of CLABSI rates.
63. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52:e162-e193. Developed by the CDC's Healthcare Infection Control Practices Advisory Committee, this guideline is an update to the 2002 version in Ref. [57].
64. Furuya EY, Dick A, Perencevich EN, et al. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS One 2011; 6:e15452. This cross-sectional study of 250 hospitals reporting data on CLABSI to the NHSN found that a central line bundle was associated with a lower incidence of CLABSI only when compliance with the bundle was monitored and was high..